Azenta Inc (AZTA)
Azenta Authorizes $250 Million Share Repurchase Program
Azenta Authorizes $250 Million Share Repurchase Program
Azenta Authorizes $250 Million Share Repurchase Program
GENFIT: GNS561 Shows Promising Antitumor Activity in Combination Therapy
Perrigo Company plc (PRGO) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Baxter International, Inc. (BAX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
MLTX Investor Deadline Alert: MoonLake (MLTX) Class Action Lawsuit – Hagens Berman Scrutinizing Nanobody Superiority Claims After 90% Plunge; December Lead Plaintiff Deadline Looms
Ocugen CEO to Present at Oppenheimer Movers in Rare Disease Summit
Ascend Wellness Holdings Announces Partnership With Mister Jones in New Jersey
Owlet Baby Care Inc. - Owlet Launches Owlet360™ in the UK and Ireland, Bringing Data-Driven Reassurance to More Families
AIM ImmunoTech Announces Release of the Next CEO Corner Segment